Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.RegeneRx eye drops treat dry eye syndrome in study
Conducted by ORA, the trial demonstrated the safety and efficacy of the drug in a number of key Controlled Adverse Environment (CAE)-related parameters. The study, which did not
Conducted by ORA, the trial demonstrated the safety and efficacy of the drug in a number of key Controlled Adverse Environment (CAE)-related parameters. The study, which did not
The double-blind, multicenter, placebo-controlled, randomized study is designed to assess the safety, tolerability, and efficacy of AVP-923. The primary efficacy endpoint will be measured based on the Numeric
As part of the agreement, Celgene, which will commit $45M to Quanticel during alliance term, will acquire an equity stake in Quanticel and will retain an option to
The rights include ATN-103 and PF-05230905 products. Ablynx will also acquire Pfizer intellectual property and know-how with regarding to the anti-TNF-alpha programmes and will have access to Pfizer’s
The study also confirmed that inhibition of miR-15 can save cardiomyocytes from death during myocardial infarction. MiRagen Therapeutics president and CEO William S Marshall said that the data
The open-label, multiple-dose, dose-escalation study will also assess the impact of SNS01-T on time to relapse or progression and tumor response using multiple metrics. Senesco president and CEO
Qnexa is a once-a-day, oral investigational drug candidate which treats weight loss, type 2 diabetes and obstructive sleep apnea. FDA assigned a six-month, or class 2, review classification
APC-100 prevents the occurrence or recurrence of prostate cancer, the company claims. The drug is an orally available anti-androgenic/anti-inflammatory, signal transduction inhibitor which is said to have high
The funding is intended for improvements in manufacturing facility. Aoxing Pharma Chairman and CEO Zhenjiang Yue said the company is happy for the continued support from the government
GMOL is used in China to treat brain ischemia and infarction, coronary heart diseases, memory dysfunction and other neurological disorders. Gingko extracts mainly comprise flavonoids and terpenoids. Flavonoids